Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109571 · ClinicalTrials.gov registry record · NA
Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders
A NA study, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 433
- Enrollment target
NCT06109571: Active NA study, sponsored by University of Wisconsin, Madison.
NCT06109571 is a NA study that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 433 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06109571, a NA study, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 433 participants
- Enrollment target
Study Summary
The current protocol aims to enroll up to 806 participants from 8 study sites in a clinic-supported intervention which will connect them to Vivent Health care team and a cohort of peer mentors for a year-long intervention period to support patient HIV care to maintain viral suppression and clinic appointments.
Primary Outcome
Using the stepped-wedge design to assess Effectiveness, each site will function as its own control or "usual care" group prior to implementation of Connections. (Aim 1)
Interventions
- DEVICE Connections App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 433 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2027-03 |
| Phase | NA |
What the registry record for NCT06109571 still lists
NCT06109571 is an interventional study that assigns participants to a tested intervention. The registered 433 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Connections App is the first listed.
NCT06109571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06109571 about?
NCT06109571 is a clinical study titled "Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders". The current protocol aims to enroll up to 806 participants from 8 study sites in a clinic-supported intervention which will connect them to Vivent Health care team and a cohort of peer mentors for a year-long intervention period to support patient HIV care to maintain viral suppression and clinic ap...
What is the current status of trial NCT06109571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 433 participants. The study started on 2023-12-04. Estimated completion is 2027-03.
What interventions are being tested in trial NCT06109571?
The interventions under investigation include: Connections App (DEVICE).
Who is sponsoring clinical trial NCT06109571?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06109571's enrollment target sits among peer trials
433 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI